Twist Bioscience (TWST) Shares Outstanding (Weighted Average) (2017 - 2026)
Twist Bioscience has reported Shares Outstanding (Weighted Average) over the past 10 years, most recently at $61.4 million for Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 2.91% to $61.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $61.4 million through Mar 2026, up 2.91% year-over-year, with the annual reading at $59.8 million for FY2025, 3.09% up from the prior year.
- Shares Outstanding (Weighted Average) was $61.4 million for Q1 2026 at Twist Bioscience, up from $61.1 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $61.4 million in Q1 2026 and troughed at $51.7 million in Q1 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $57.8 million (2024), against an average of $57.7 million.
- Year-over-year, Shares Outstanding (Weighted Average) rose 17.56% in 2022 and then rose 1.34% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $56.4 million in 2022, then rose by 1.87% to $57.5 million in 2023, then increased by 2.9% to $59.2 million in 2024, then increased by 3.24% to $61.1 million in 2025, then rose by 0.5% to $61.4 million in 2026.
- Per Business Quant, the three most recent readings for TWST's Shares Outstanding (Weighted Average) are $61.4 million (Q1 2026), $61.1 million (Q4 2025), and $59.8 million (Q3 2025).